Use of evidence-based therapy in heart failure with reduced ejection fraction across age strata (vol 24, pg 1047, 2022)

被引:0
|
作者
不详
机构
关键词
D O I
10.1002/ejhf.2691
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1995 / 1995
页数:1
相关论文
共 50 条
  • [11] Rapid evidence-based sequencing of foundational drugs for heart failure and a reduced ejection fraction
    Packer, Milton
    McMurray, John J. V.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (06) : 882 - 894
  • [12] Clinician challenges to evidence-based prescribing for heart failure and reduced ejection fraction: A qualitative evaluation
    Trinkley, Katy E.
    Dafoe, Ashley
    Malone, Daniel C.
    Allen, Larry A.
    Huebschmann, Amy
    Khazanie, Prateeti
    Lunowa, Cali
    Matlock, Daniel C.
    Suresh, Krithika
    Rosenberg, Michael A.
    Swat, Stanley A.
    Sosa, Aracely
    Morris, Megan A.
    [J]. JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2023, 29 (08) : 1363 - 1371
  • [13] Digoxin use in contemporary heart failure with reduced ejection fraction: An analysis from the Swedish Heart Failure Registry (vol 8, pg 756,year 2022)
    Kapelios, Chris J.
    Lund, Lars H.
    Benson, Lina
    Dahlstrom, Ulf
    Rosano, Giuseppe M. C.
    Hauptman, Paul J.
    Savares, Gianluigi
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2023, 9 (03) : 292 - 292
  • [14] The safety and tolerability of beta blockers in heart failure with reduced ejection fraction: is the current underutilization of this evidence-based therapy justified?
    Kiel, Richard. G.
    Deedwania, Prakash
    [J]. EXPERT OPINION ON DRUG SAFETY, 2015, 14 (12) : 1855 - 1863
  • [15] How much can ejection fraction be improved in patients with heart failure with reduced ejection fraction (HFrEF) by the early introduction of evidence-based heart failure medication?
    White, J. Joseph
    Caspi, T.
    Arabi, P.
    Mcgrath, S.
    Arshad, A.
    Small, J.
    Wilkins, S.
    Ferreira, B.
    Bowker, T. J.
    Roy, S. Dutta
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 196 - 196
  • [16] The benefits of the earlier use of sacubitril/valsartan in de novo heart failure with reduced ejection fraction patients (vol 9, pg 2435, 2022)
    Oh, J. -H
    Lee, J. -M
    Lee, H. -J
    Hwang, J.
    Lee, C. H.
    Cho, Y. -K
    Park, H. -S
    Yoon, H. -J
    Chung, J. -W
    Kim, H.
    Nam, C. -W
    Han, S.
    Hur, S. -H
    Youn, J. -C
    Kim, I. -C
    [J]. ESC HEART FAILURE, 2022,
  • [17] Heart Failure With Reduced Ejection Fraction: A Review (vol 324, pg 488, 2020)
    Murphy, S. P.
    Ibrahim, N. E.
    Januzzi, J. L., Jr.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (20): : 2107 - 2107
  • [18] Impact of Worsening Heart Failure on Long-Term Prognosis in Patients With Heart Failure With Reduced Ejection Fraction (vol 184, pg 63, 2022)
    Chimed, Surenjav
    Stassen, Jan
    Galloo, Xavier
    Meucci, Maria Chiara
    van der Bijl, Pieter
    Knuuti, Juhani
    Delgado, Victoria
    Marsan, Nina Ajmone
    Bax, Jeroen J.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2023, 198 : 137 - 137
  • [19] Iron status in patients with heart failure with reduced ejection fraction across different age groups
    Drozd, M.
    Kasztura, M.
    Tkaczyszyn, M.
    Rozentryt, P.
    Nowak, J.
    Polonski, L.
    Malyszko, J.
    Koc-Zorawska, E.
    Banasiak, W.
    Ponikowski, P.
    Jankowska, E. A.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 447 - 448
  • [20] Evidence-based heart failure treatment effect on mortality despite ejection fraction
    Tamariz, Leo
    Palacio, Ana
    Lopez, Barbara
    Arcement, Lee
    Macedo, Francisco Igor
    Macedo, Fancisco Yuri
    Hebert, Kathy
    [J]. CIRCULATION, 2008, 117 (21) : E426 - E426